Pharmaceutical Business review

Teva launches generic anti-obesity drug

The drug is indicated in conjunction with a mildly hypocaloric diet for the treatments of obese patients with associated risk factors.

Teva Commercial Director Kim Innes said they are the first company to launch generic Orlistat in the UK.